Three sisters lose 18 stone between them on the same diet
Three sisters lose 18 stone between them on the same diet
They were facing surgery, diabetes and blindness before working together to cut their weight
Emma, Katie and Tammy went on a weight-loss journey together
Three sisters who have lost more than 18 stone (114.3kg) between them by following an 800-calorie-a-day diet have said it transformed their lives more than they could have imagined. Emma Castle, 48, reached her heaviest weight of 22 stone 6lb (143.1 kg), wearing a size 24, in summer 2023 and realised she needed to make a change after discovering she had high blood pressure and was pre-diabetic.
In January 2024, she began the 1:1 Diet by Cambridge Weight Plan, a step-by-step weight-loss programme that provides one-to-one consultant support and starts with 800 calories a day through meal replacement products and a small evening meal. The NHS recommends 2,000 calories daily for women, with a 600-calorie reduction suggested for weight loss.
Emma is now 14 stone 6lb (92.1 kg) and a size 16, making everyday actions easier, such as walking, doing housework, and even sitting on a bus without taking up two seats. She has also become a consultant for the 1:1 Diet. Tammy Fisher, 46, started the same diet at 16 stone 5lb (104.1 kg), wearing a size 20, desperate for change after years of feeling 'hopeless' and even considering gastric surgery, but has since slimmed down to 10 stone 12lb (68 kg) and a size 12. She is now also a consultant.
Katie Nutt, 46, who does not work because of health reasons, began the diet in February 2024 and has gone from 17 stone 4lb (110.3 kg) and a size 22 to 12 stone 1lb (76.7 kg) and a size 14 – she has hypertension on the brain and since losing weight her condition has stabilised.
Tammy, who, like her sisters, lives in Abingdon, Oxfordshire, told PA Real Life: 'It makes you feel in control of what you're eating. I feel like it just works for us even though some people might think it's not enough calories to start with. I thought surgery was my only option but how wrong I was – I don't need any injection or surgery – I did it myself and it's just unreal.'
Emma reached her heaviest weight of 22 stone 6lb in the summer of 2023, after years of overeating and having large bars of chocolate most evenings. But after a visit to her GP revealed she had high blood pressure and was pre-diabetic she slowly began to realise she may need to make some changes.
In January 2024 she began following the 1:1 Diet by Cambridge Weight Plan which is a tailored weight-loss plan that provides one-to-one consultant support for every dieter and became a consultant for the diet too. She said: 'I realised that actually I'm not going to be able to get through life unscathed if I continue as I am.'
The diet consists of several steps. Step one involves replacing your everyday food for nutritionally complete meal replacement products. Emma started at step two which includes three 1:1 products daily – such as snack bars or porridge – along with a 200-calorie evening meal made from ingredients such as chicken and vegetables, with no carbohydrates.
By May 2024, Emma had lost four stone (25.4 kg), and a check-up confirmed her blood pressure and blood sugar levels were within the normal range. She said: 'It made it all worth it, I felt so much better in myself. It's really quite life changing, losing that amount of weight, and it's just everyday things that you notice are easier, like walking, housework, sitting on a bus and not taking up nearly two seats.'
Tammy also began the 1:1 Diet in January 2024, becoming a consultant too, following the same 800-calorie plan. At the time, she weighed 16 stone 5lb (104.1 kg) – the 'biggest' she had 'ever been' – and was 'desperate' to make a change.
The sisters supported each other throughout the process. (L to R: Tammy, Emma and Katie) (Collect/PA Real Life)
She had been considering gastric surgery, even contacting private hospitals and arranging payment plans, but was inspired by Emma to try the diet instead, avoiding a procedure that could have cost around £10,000. She explained: 'I got to the point where I didn't like what I saw in the mirror at all. I didn't like my clothes … friends would invite me out and I wouldn't go, and I used to cry a lot and think it was all hopeless.'
However, after just a few days on the plan, and despite feeling light-headed during the initial 'detox', she suddenly got a 'spring in her step'. Katie began the diet in February 2024, starting at 17 stone 4lb (110.3 kg).
Katie, who was on the waiting list for gastric sleeve surgery because of hypertension on the brain, was advised to lose weight to relieve her symptoms such as headaches and neck and back pain. Since following the diet – also consuming 800 calories a day – she has halved her pain medication.
There had also been a risk of her going blind, as the condition was causing pressure on her optic nerves, but her eyesight is now stable. Katie said: 'I think my family have noticed a huge difference – I used to look so poorly all the time and my kids used to just think, 'God, mum's in bed again'. Now they see me up sprightly.'
Together, the sisters have lost more than 18 stone (114.3 kg), with Emma shedding eight stone (50.8 kg), Tammy five stone 7lb (35.4 kg), and Katie five stone 3lb (33.5 kg). All three sisters, who are 5ft 2in, started in the obese category – Emma had a BMI of 57, Tammy had a BMI of 42, and Katie had a BMI of 44.
After losing weight, Emma's BMI is the lowest level of obese at 36, Tammy moved into the overweight category at 28, and Katie reached the borderline between overweight and obese at 30. Emma said: 'I don't actually think my brain is caught up in my body … I keep buying bigger sizes thinking they're the right size.'
When the sisters are closer to their goal weights, they will eventually move on to the final steps, with their calories increasing each time. The final step involves eating one 1:1 product a day and eating a healthy diet of around 1,500 calories each day, while keeping active and working towards maintaining weight.
The sisters believe their weight-loss journey has brought them closer, supporting each other along the way. 'Every celebration used to revolve around food,' said Emma.
'But now we spend that money on experiences, like holidays together and we've found new ways to reward ourselves. It's a whole new mindset.' Since losing the weight, their lives have changed beyond their 'wildest imaginations' – Tammy and Katie are no longer considering surgery and they all feel healthier, with more energy, and have more confidence than ever.
Looking ahead, the sisters believe the diet will be 'part of (their) lives for the rest of (their) lives', and Emma and Tammy are excited to continue their journeys by helping others as consultants.
Article continues below
For more information about the 1:1 Diet visit: www.one2onediet.com.
If you are living with obesity, your GP can offer you advice about improving your lifestyle and losing and managing your weight safely. For more information, visit: www.nhs.uk/conditions/obesity/treatment.
If you were affected by this content or are struggling with an eating disorder, support is available at www.beateatingdisorders.org.uk.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Scotsman
6 hours ago
- Scotsman
How Nigel Farage let his mask slip and revealed what he'd really do to Scotland
Sign up to our daily newsletter – Regular news stories and round-ups from around Scotland direct to your inbox Sign up Thank you for signing up! Did you know with a Digital Subscription to The Scotsman, you can get unlimited access to the website including our premium content, as well as benefiting from fewer ads, loyalty rewards and much more. Learn More Sorry, there seem to be some issues. Please try again later. Submitting... On Monday, Nigel Farage finally hauled himself away from his holidays and found his way up to Scotland (apparently for only the third time in five years). And while the media can never resist a circus, during his interviews with journalists, Farage let the mask slip. The Clacton MP blurted out his plans to replace the Barnett Formula – the funding mechanism that ensures Scotland gets a fair deal for devolved services based on the UK Government's spending in England. Advertisement Hide Ad Advertisement Hide Ad It was as a result of the Barnett Formula that the UK Labour government delivered the largest budget settlement for the Scottish Government in the history of devolution and £5.2 billion of additional funding for Scottish public services. This means that overall spending per head of population can be as much as 17 per cent higher in Scotland. Nigel Farage is an English nationalist who doesn't care about Scotland (Picture: Carl Court) | Getty Images Historic imbalances Last year, the Scottish Government's own figures found that spending in Scotland outstripped all the revenues raised by over £22bn, even when North Sea taxes were taken into account. That means people in Scotland benefit from £2,417 more per head of additional spending compared to the UK average. In other words, it's the Barnett Formula that addresses historic imbalances and ensures that wealth is redistributed throughout the UK so that everyone has the best chance of accessing our NHS and using public services, no matter where they live. Advertisement Hide Ad Advertisement Hide Ad But Farage isn't interested in delivering for Scotland. He is an English nationalist who called as early as 2014 for the Barnett Formula to go, and as leader of the so-called UK Independence Party told the BBC: "We've heard a lot from Scotland but the tail cannot go on wagging the dog any longer." Farage does not only have contempt for Scotland – it extends to our NHS. He has repeatedly called for the NHS to be privatised and replaced with health insurance. In other words, forcing working families to pay from their own pockets for lifesaving care. Feeding off voters' despair Now, with his comments on scrapping the Barnett Formula, the Reform leader has said the quiet part out loud. Reform would trash our public services to win over voters in its English heartlands. I understand why Nigel Farage appeals to voters. He's like the scam artist who targets people at their lowest – and the reality is that after nearly two decades of the SNP's managed decline, Scots are fed up. Advertisement Hide Ad Advertisement Hide Ad But Reform are feeding off this despair without offering any real solutions of their own. So let's be under no illusion – the former stockbroker is not interested in Scotland. He doesn't understand Scotland and he really doesn't care about Scotland. Rather than trying to come up with genuine ideas to improve our NHS or public services, Farage is spending thousands on racist adverts targeting Scottish Labour's leader, Anas Sarwar. Anas is a former NHS dentist who was born and brought up in Glasgow and has spent his life campaigning for working Scots. And unlike Reform, Scottish Labour has made fixing the NHS our number one priority. Scots who are sick of the SNP's incompetence are right to want change – but it's Scottish Labour that is ready to deliver it.
Daily Record
6 hours ago
- Daily Record
Former Stirling care home site could be sold off for housing
The facility was briefly used for people recuperating from Covid more recently, but was once the focus of a campaign to save it from the axe. A former Stirling care home site, which was once at the heart of a heated local campaign, looks to be on the cusp of being sold for housing. Beech Gardens, off Polmaise Road in Torbrex, is situated within the original curtilage of the listed Batterflatts House and was purpose-built as a care facility. In recent years the home was closed and declared surplus as a part of the reconfiguration of care services across the Forth Valley, following the creation of the Stirling Care Village. In 2009, however, it was at the centre of a local campaign to keep it open after it was threatened with the axe in council cuts. While the heated battle resulted in it being given a stay of execution, its use was eventually phased out and it was used for respite care for a period. During the Covid pandemic it was upgraded, along with Allan Lodge, to support NHS patients in recovery being moved out of the hospital environment. NHS used the facility briefly, and the building was returned to the council. In a report due before a special meeting of Stirling Council on Thursday, officials said: 'Since the pandemic, the property has attracted interest from several parties, from within the council, and a formal asset transfer request was subsequently withdrawn. 'Current running costs for 2024-2025 were £32,953, which includes £11,641 of rates, £6,404 standing charges on utilities, and £14,908 on security. 'An external marketing agent was appointed to market several council-owned surplus properties and development sites, including Beech Gardens.' The officials said any changes to the site must protect the character and appearance of the designated conservation area and the adjacent listed building - with a single-story structure essential. Any future development should also prioritise the use of the existing building, unless it can be demonstrated that the structural condition makes retention 'unfeasible at a reasonable cost and all reasonable efforts to retain, repair and reuse the building have been exhausted'. The site is said to be 'well-suited for residential purposes, including private housing, social housing, or residential care'. At the closing date in March, there were five offers received, ranging from £500,000 to £150,000. Two offers had no suspensive conditions, or the offer was unconditional. Two offers were subject to either condition surveys or title and site services investigations. One offer was subject to obtaining satisfactory funding. The report added: 'Given its position as the most financially advantageous and that it is not subject to any suspensive conditions, it is recommended that Urban Nest Scotland Limited's offer be taken forward as the preferred bidder. 'Urban Nest Scotland Ltd proposes to develop the site for private housing and is in a position to progress with the conclusion of missives on the council approval. 'Urban Nest has held initial discussions with the Planning team regarding their development plans. 'This disposal will result in the release of the property, the achievement of the capital receipt, and the reduction of revenue budget pressure in this fiscal year.' At Thursday's special meeting, councillors will be asked to approve the preferred bidder and disposal of Beech Gardens.
NBC News
6 hours ago
- NBC News
Wegovy use among U.S. teens up 50% as obesity crisis worsens
American teens are increasingly turning to the weight-loss drug Wegovy as more families and their doctors gain confidence in its use for young people with obesity, new data shared with Reuters shows. The average rate of teens beginning treatment with the highly effective Novo Nordisk drug grew 50% last year to 14.8 prescriptions per 100,000 adolescents, according to an analysis by health data firm Truveta. That's up from a rate of 9.9 prescriptions per 100,000 in 2023, the first full year that Wegovy was available to children aged 12 and older. The average rate climbed further during the first three months of this year, reaching 17.3 new prescriptions per 100,000. That still represents a minute fraction of the estimated 23,000 out of every 100,000 teens in the country who are living with obesity, and is far slower than the uptake among U.S. adults. 'It's promising that more young people are using these medications, but it's still a very small percentage of patients with severe obesity that are getting access to them,' said Dr. Cate Varney, director of obesity medicine at the University of Virginia Health system. 'When lifestyle changes alone are insufficient, we need these additional tools.' For its analysis, Truveta reviewed the electronic health records of 1.3 million patients ages 12 through 17. The data covers 30 U.S. health systems with more than 900 hospitals and 20,000 clinics across the country. The analysis did not include other GLP-1 drugs, including Novo's Ozempic and Eli Lilly's LLY.N Zepbound, which are not approved to treat obesity in adolescents, or compounded versions of these therapies. Wegovy became an option to treat adolescents in late 2022 after decades in which the conventional approaches of diet, exercise and counseling largely failed. About 8 million American teens, or 23% of people ages 12 to 19, have obesity, up from 5% in 1980, according to U.S. government data. Young people with obesity run a much higher risk of developing chronic, costly, life-shortening conditions like type 2 diabetes and cardiovascular and liver diseases. In January 2023, the American Academy of Pediatrics strongly recommended that doctors provide weight-loss drugs to children with obesity starting at age 12. Yet the medical community has not uniformly embraced GLP-1s for adolescents. Some doctors are hesitant because the drugs' long-term safety for children during a critical phase of development is unknown, and the treatments may need to be used indefinitely. Overall, there are limited options for many teens and their parents because insurance plans often do not cover any treatment for obesity, including intensive behavioral counseling, visits with a dietician or the new GLP-1 medications. At Nemours Children's Hospital in Wilmington, Delaware, the Healthy Weight and Wellness Clinic treated about 2,000 adolescent patients last year. About 25% were prescribed Wegovy or another GLP-1 medication, said Dr. Thao-Ly Phan, the clinic's medical director. The number of adolescents with a GLP-1 prescription nearly doubled from 2023. On average, their patients taking a GLP-1 drug lost 15 pounds (6.8 kg) within 6 to 12 months, and nearly 30 pounds after more than a year. For many of the other patients, the medications were not an option, either because of insurance hurdles or concern within families about potential risks. Other teens opted for lifestyle changes or older, cheaper weight-loss drugs, with some success. 'It is important for us to continue to monitor and better understand outcomes from the medications — both positive and negative — before widespread use,' Phan said. U.S. Health Secretary Robert F. Kennedy Jr. has criticized the idea of prescribing Ozempic or Wegovy widely to children to treat obesity. In a federal health report he released last month, GLP-1 drugs were cited as an example of the 'overmedicalization of our kids.' It noted a lack of 'long-term safety data, raising the specter of unforeseen problems that interrupt, damage, or impair metabolism and growth development.' Novo in a statement said semaglutide, the active ingredient in Wegovy and Ozempic, 'did not appear to affect growth or pubertal development' during its clinical trials involving teens. For many adults, Novo said, obesity starts in childhood or adolescence, and 'we are confident in the proven safety and efficacy of our GLP-1 medicines.' Eli Lilly's weight-loss drug Zepbound is in late-stage clinical trials for use by adolescents. Lilly told Reuters that 'there has been no evidence to date suggesting impairment in growth or metabolism' from GLP-1 medications. Dr. Robert Siegel, a pediatrician and director of the Center for Better Health and Nutrition at Cincinnati Children's Hospital, said about 15% of adolescents being treated there were prescribed Wegovy or a similar GLP-1 medication from July 2021 to July 2023. They include patients being treated for type 2 diabetes for which the GLP-1 drugs were originally developed. Siegel said he prefers to start teens on three to six months of intensive lifestyle management before even considering medication. While obesity specialists can help navigate potential risks from the drugs, many primary-care providers need more training, he said. They may not have the equipment to monitor for the loss of muscle mass — a side effect of these medicines — or lack the resources to work with families over an extended period on healthier eating and exercise. 'These medications are likely to be needed for a very long time to maintain weight,' Siegel said, 'and we only have a relatively short-term experience with them.'
